Mark Gehring is a co-founder and chief strategy officer of HealthMyne, an oncology imaging analytics company. Previously, Mark co-founded and served as president of Propeller Health, a digital therapeutic for asthma and COPD, employing sensors and mobile apps. In the 2000s, Mark was co-founder and CEO of UltraVisual Medical Systems, which produced a diagnostic imaging (PACS) platform, merged with another startup, Emageon, and executed a successful IPO in 2005. In the 1990s, Mark was co-founder and CEO of Geometrics, which developed the first commercial 3D radiation treatment planning system, still the leading system worldwide, now marketed by Philips Medical Systems. The products developed by UltraVisual and Geometrics have generated over $2 billion in cumulative revenue. Mark has a degree in biomedical engineering from Marquette University and is a self-taught software developer.